CDC Study on Drug Resistant TB Published in The Lancet Infectious Diseases
A CDC study, published in The Lancet Infectious Diseases,External
CDC researchers, using a complex mathematical model that brought together the best available data from multiple sources, found:
-
- The proportion of new drug resistant TB cases in these four high-burden countries will increase by 2040 unless there are major changes in the global response
- Fewer cases over time will be caused by acquired drug resistance during TB treatment
- These findings suggest that person-to-person transmission, rather than inadequate or ineffective treatment, will increasingly drive the epidemic over the next two decades
The study findings have important implications for global TB efforts and point to an urgent need to transform the global community’s approach to controlling this deadly disease. Focusing solely on curing people with TB and drug-resistant TB will not be enough to halt the epidemic. According to study authors, controlling the growing threat of drug resistant TB around the world requires a concerted effort on a number of fronts such as:
-
- Strengthening infection control and contact tracing measures
- Intensifying efforts to stop the spread of TB in households, health centers and communities
- Developing more effective diagnostic tests that can rapidly detect drug resistance
For more information on this analysis and the growing threat of drug resistant TB, see downloadable resources below:
Downloadable Resources
Read more about CDC’s efforts every day to combat TB globally.
To stay in the know about global HIV and TB, please subscribe.